MedWatch

Coloplast moves important production to country on tax haven watch list

So far, Coloplast has spent half a billion kroner (USD 75.9m) on establishing two new factories in Costa Rica, which the EU says is close to being a functioning tax haven. The medtech company rejects this as being a factor in the move, saying activities can occur in all countries, and it is openly publishing tax figures – just not for Costa Rica.

Photo: Coloplast/PR

A huge undertaking is well underway, as Coloplast is constructing a new factory in Central American country Costa Rica. While the country isn't quite on the EU's blacklist of non-cooperative jurisdictions for tax purposes, it has made it onto the "grey list."

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs